Supernus Pharmaceuticals (SUPN) Return on Capital Employed Growth (1y) (2013 - 2026)
Supernus Pharmaceuticals (SUPN) Return on Capital Employed Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | 333.00 |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | -469.00 |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 8.00 |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | 220.00 |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 802.00 |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | 340.00 |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 573.00 |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Supernus Pharmaceuticals | 2.74 Bn | 2.37 Bn | 185.39 Mn | -1,579.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,579.00 |
| Dec 31, 2025 | -1,335.00 |
| Sep 30, 2025 | -916.00 |
| Jun 30, 2025 | 329.00 |
| Mar 31, 2025 | 832.00 |
| Dec 31, 2024 | 821.00 |
| Sep 30, 2024 | 271.00 |
| Jun 30, 2024 | 107.00 |
| Mar 31, 2024 | -625.00 |
| Dec 31, 2023 | -510.00 |
| Sep 30, 2023 | 115.00 |
| Jun 30, 2023 | -400.00 |
| Mar 31, 2023 | -56.00 |
| Dec 31, 2022 | -202.00 |
| Sep 30, 2022 | -740.00 |
| Jun 30, 2022 | -607.00 |
| Mar 31, 2022 | -576.00 |
| Dec 31, 2021 | -681.00 |
| Sep 30, 2021 | -2,712.00 |
| Mar 31, 2021 | -394.00 |